Longitudinal study of painful diabetic neuropathy in the Zucker diabetic fatty rat model of type 2 diabetes: impaired basal G-protein activity appears to underpin marked morphine hyposensitivity at 6 months.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Pain medicine (Malden, Mass.)

• Publication date

  2011-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1526-4637.2011.01067.xPMID 21332939
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of effect of aqueous extract of Enicostemma littorale Blume in streptozotocin-induced type 1 diabetic rats.

  2010cited by this paper
• Diabetic cardiomyopathy: effects of fenofibrate and metformin in an experimental model – the Zucker diabetic rat

  2009cited by this paper
• Heme oxygenase system enhances insulin sensitivity and glucose metabolism in streptozotocin-induced diabetes.

  2009cited by this paper
• Distal Degenerative Sensory Neuropathy in a Long-Term Type 2 Diabetes Rat Model

  2008cited by this paper
• Time course of pain sensation in rat models of insulin resistance, type 2 diabetes, and exogenous hyperinsulinaemia

  2008cited by this paper
• Swim training prevents hyperglycemia in ZDF rats: mechanisms involved in the partial maintenance of beta-cell function.

  2008cited by this paper
• Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus.

  2008cited by this paper
• Involvement of p38 Mapkinase in attenuation of antinociceptive effect of morphine in diabetic mice.

  2007cited by this paper
• Involvement of mu1-opioid receptor on oxycodone-induced antinociception in diabetic mice.

  2007cited by this paper
• Peripheral participation of cholecystokinin in the morphine-induced peripheral antinociceptive effect in non-diabetic and diabetic rats.

  2007cited by this paper
• Oxycodone and morphine have distinctly different pharmacological profiles: Radioligand binding and behavioural studies in two rat models of neuropathic pain

  2007cited by this paper
• Reduced Expression of the KATP Channel Subunit, Kir6.2, is Associated with Decreased Expression of Neuropeptide Y and Agouti‐Related Protein in the Hypothalami of Zucker Diabetic Fatty Rats

  2007cited by this paper
• Mitogen-activated protein kinase upregulation reduces renal D1 receptor affinity and G-protein coupling in obese rats.

  2007cited by this paper
• Characterization of the antinociceptive effects of oxycodone in diabetic mice.

  2006cited by this paper
• Diabetic Neuropathy Differs in Type 1 and Type 2 Diabetes

  2006cited by this paper
• Inhibitory effects of astragaloside IV on diabetic peripheral neuropathy in rats.

  2006cited by this paper
• Taurine reverses neurological and neurovascular deficits in Zucker diabetic fatty rats.

  2006cited by this paper
• Alteration of the gene and protein levels of insulin-like growth factors in streptozotocin-induced diabetic male rats.

  2006cited by this paper
• Unmyelinated fiber sensory neuropathy differs in type 1 and type 2 diabetes

  2005cited by this paper
• Modulatory Role of Green Tea Extract on Antinociceptive Effect of Morphine in Diabetic Mice

  2005cited by this paper
• Experimental Rat Models of Types 1 and 2 Diabetes Differ in Sympathetic Neuroaxonal Dystrophy

  2004cited by this paper
• Insulin Deficiency Rather than Hyperglycemia Accounts for Impaired Neurotrophic Responses and Nerve Fiber Regeneration in Type 1 Diabetic Neuropathy

  2003cited by this paper
• Analysis of the Zucker Diabetic Fatty (ZDF) type 2 diabetic rat model suggests a neurotrophic role for insulin/IGF-I in diabetic autonomic neuropathy.

  2003cited by this paper
• Diabetic neuropathy: inhibitory G protein dysfunction involves PKC‐dependent phosphorylation of Goα

  2003cited by this paper
• Antinociceptive Effect of Morphine, but not &mgr; Opioid Receptor Number, Is Attenuated in the Spinal Cord of Diabetic Rats

  2003cited by this paper
• Functional &mgr; Opioid Receptors Are Reduced in the Spinal Cord Dorsal Horn of Diabetic Rats

  2002cited by this paper
• Role of ghrelin in streptozotocin-induced diabetic hyperphagia.

  2002cited by this paper
• Spinal and supraspinal components of opioid antinociception in streptozotocin induced diabetic neuropathy in rats

  2001cited by this paper
• Impaired inhibitory G-protein function contributes to increased calcium currents in rats with diabetic neuropathy.

  2001cited by this paper
• Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death.

  2001cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Chronic Neuropathic Pain: Mechanisms and Treatment

  2000cited by this paper
• A comparison of diabetic polyneuropathy in Type II diabetic BBZDR/Wor rats and in Type I diabetic BB/Wor rats

  2000cited by this paper
• Effects of peroxisome proliferator‐activated receptor‐α and ‐γ agonist, JTT‐501, on diabetic complications in Zucker diabetic fatty rats

  2000cited by this paper
• Thermal, but not mechanical, nociceptive behavior is altered in the Zucker Diabetic Fatty rat and is independent of glycemic status.

  1999cited by this paper
• Is the reduced efficacy of morphine in diabetic rats caused by alterations of opiate receptors or of morphine pharmacokinetics?

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Effect of a high-fat diet on food intake and hypothalamic neuropeptide gene expression in streptozotocin diabetes.

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Insulin-like growth factor (IGF) gene expression is reduced in neural tissues and liver from rats with non-insulin-dependent diabetes mellitus, and IGF treatment ameliorates diabetic neuropathy.

  1997cited by this paper
• Spinal pharmacology of tactile allodynia in diabetic rats

  1997cited by this paper
• Primary preventive and secondary interventionary effects of acetyl-L-carnitine on diabetic neuropathy in the bio-breeding Worcester rat.

  1996cited by this paper
• Nerve fiber regeneration following axotomy in the diabetic biobreeding Worcester rat: the effect of ARI treatment.

  1996cited by this paper
• Prazosin blocks the pressor but not the regional circulatory effects of diaspirin crosslinked hemoglobin.

  1994cited by this paper
• Quantitative assessment of tactile allodynia in the rat paw.

  1994cited by this paper
• Streptozotocin-induced diabetes selectively enhances antinociception mediated by δ1-but not δ2-opioid receptors

  1994cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.

  1992cited by this paper
• Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by μ-opioid agonists, but not by δ- and κ-opioid agonists

  1992cited by this paper
• Zucker Diabetic Fatty Rat as a Model for Non-insulin-dependent Diabetes Mellitus

  1990cited by this paper
• Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.

  1989cited by this paper
• Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain

  1988cited by this paper
• Evidence that endogenous enkephalins and a delta opioid receptor agonist have a common site of action in spinal antinociception.

  1988cited by this paper
• Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice.

  1987cited by this paper
• Evidence that mu-opioid receptors mediate midbrain "stimulation-produced analgesia" in the freely moving rat.

  1987cited by this paper
• Opioid b-receptor involvement in supraspinal and spinal antinociception in mice

  1987cited by this paper
• Evidence that μ-opioid receptors mediate midbrain “stimulation-produced analgesia” in the freely moving rat

  1987cited by this paper
• Axo-glial dysjunction. A novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic bio-breeding rat.

  1986cited by this paper
• Axonal atrophy in sensory nerves of the diabetic BB‐Wistar rat: A possible early correlate of human diabetic neuropathy

  1983cited by this paper
• Distribution of opiate receptors in the monkey brain: an autoradiographic study.

  1982cited by this paper
• Autoradiographic localization of opiate receptors in rat brain. III. The telencephalon.

  1977cited by this paper
• Autoradiographic localization of opiate receptors in rat brain. II. The brain stem.

  1977cited by this paper

• Diroximel Fumarate Acts Through Nrf2 to Attenuate Methylglyoxal-Induced Nociception in Mice and Decrease ISR Activation in DRG Neurons

  2025cites this paper
• Multimodal Comparison of Diabetic Neuropathy in Aged Streptozotocin-Treated Sprague–Dawley and Zucker Diabetic Fatty Rats

  2022cites this paper
• Selection of experimental models mimicking human pathophysiology for diabetic microvascular complications

  2022cites this paper
• Peripheral Neuropathy Phenotyping in Rat Models of Type 2 Diabetes Mellitus: Evaluating Uptake of the Neurodiab Guidelines and Identifying Future Directions

  2022cites this paper
• Nonopioid analgesics discovery and the Valley of Death: EMA401 from concept to clinical trial

  2022cites this paper
• The PPARγ agonist pioglitazone produces a female-predominant inhibition of hyperalgesia associated with surgical incision, peripheral nerve injury, and painful diabetic neuropathy.

  2021cites this paper
• Hyperbaric oxygen enhances collagen III formation in wound of ZDF rat.

  2021cites this paper
• Sildenafil and Vinpocetine Promote Wound Healing in Diabetic Rats

  2020cites this paper
• Nitric oxide modulates μ‐opioid receptor function in vitro

  2019cites this paper
• Diabetes mellitus attenuates the pressure response against hypotensive stress by impairing the sympathetic regulation of the baroreflex afferent arc.

  2019cites this paper
• Morphine hyposensitivity in streptozotocin‐diabetic rats: Reversal by dietary l‐arginine treatment

  2018cites this paper
• Behavioural, morphological and electrophysiological assessment of the effects of type 2 diabetes mellitus on large and small nerve fibres in Zucker diabetic fatty, Zucker lean and Wistar rats

  2018cites this paper
• The Somatostatin Receptor-4 Agonist J-2156 Alleviates Mechanical Hypersensitivity in a Rat Model of Breast Cancer Induced Bone Pain

  2018cites this paper
• Effect of vardenafil on diabetic foot ulcer (DFU) in rats

  2018cites this paper
• Morphine hyposensitivity in streptozotocin-diabetic rats: Reversal by dietary l-arginine treatment.

  2017cites this paper
• Pioglitazone Inhibits the Development of Hyperalgesia and Sensitization of Spinal Nociresponsive Neurons in Type 2 Diabetes.

  2016cites this paper
• Impaired expression of neuronal nitric oxide synthase in the gracile nucleus is involved in neuropathic changes in Zucker Diabetic Fatty rats with and without 2,5-hexanedione intoxication.

  2016cites this paper
• Involvement of spinal glutamate transporter-1 in the development of mechanical allodynia and hyperalgesia associated with type 2 diabetes

  2016cites this paper
• Role of Fyn-mediated NMDA receptor function in prediabetic neuropathy in mice.

  2016cites this paper
• Alternatives to the Streptozotocin-Diabetic Rodent.

  2016cites this paper
• TRANSLATIONAL RESEARCH SECTION Original Research Article Insulin Implants Prevent the Temporal Development of Mechanical Allodynia and Opioid Hyposensitivity for 24-Wks in Streptozotocin (STZ)-Diabetic Wistar Rats

  2016cites this paper
• The furoxan nitric oxide donor, PRG150, evokes dose‐dependent analgesia in a rat model of painful diabetic neuropathy

  2015cites this paper
• Electrophysiological characterization of spinal neurons in different models of diabetes type 1- and type 2-induced neuropathy in rats

  2015cites this paper
• Orofacial sensory changes after streptozotocin-induced diabetes in rats.

  2013cites this paper
• Diabetic neuropathic pain development in type 2 diabetic mouse model and the prophylactic and therapeutic effects of coenzyme Q10.

  2013cites this paper
• Characterization of cannabinoid-induced relief of neuropathic pain in rat models of type 1 and type 2 diabetes.

  2012cites this paper
• Endogenous opiates and behavior: 2011.

  2012cites this paper
• Rodent Models of Painful Diabetic Neuropathy: What Can We Learn from

  2012cites this paper
• Insulin implants prevent the temporal development of mechanical allodynia and opioid hyposensitivity for 24-wks in streptozotocin (STZ)-diabetic Wistar rats.

  2011cites this paper
• Vitamin D homeostasis is compromised due to increased urinary excretion of the 25-hydroxycholecalciferol-vitamin D-binding protein complex in the Zucker diabetic fatty rat.

  2010cites this paper